Although OS levels ARE elevated in AD, the transcriptional activation of Nrf2 is defective and/or incomplete due to reduced nuclear entry and/or defective binding to ARE (Kraft et al. 2004; Ramsey et al. 2007). This evidence concerns the gene NFE2L2 and Alzheimer disease.